EPIZYME INC (EPZM) Covered Calls

EPIZYME INC covered calls Epizyme Inc is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

You can sell covered calls on EPIZYME INC to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for EPZM (prices last updated Fri 3:30 PM ET):

EPIZYME INC (EPZM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.76 -0.04 8.76 8.77 289K - 0.6B
Covered Calls For EPIZYME INC (EPZM)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 10 0.20 8.57 2.3% 28.9%
Feb 15 10 0.35 8.42 4.2% 12.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Epizyme, Inc. operates as a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers. It is engaged in the creation of small molecule histone methyltransferase inhibitors, a new class of personalized therapeutics for the treatment of patients with genetically defined cancers, based on breakthroughs in the field of epigenetics. Epizyme was founded by H. Robert Horvitz and Yi Zhang on November 1, 2007 and is headquartered in Cambridge, MA.